Literature DB >> 18676396

Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion.

Zhaokang Cheng1, Lailiang Ou, Yi Liu, Xiaolei Liu, Fei Li, Bin Sun, Yongzhe Che, Deling Kong, Yaoting Yu, Gustav Steinhoff.   

Abstract

AIMS: Controversy exists regarding the effects of granulocyte colony-stimulating factor (G-CSF) on post-infarction remodelling, which is regulated by matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). The aim of this study was to investigate the impact of G-CSF administration on cardiac MMP/TIMP ratios and long-term remodelling in a rat model of acute myocardial infarction (MI). METHODS AND
RESULTS: Sprague-Dawley rats underwent coronary ligation to produce MI. Rats surviving the MI for 3 h were randomized to receive G-CSF (50 microg/kg/day for 5 consecutive days, n = 16) or saline (n = 10). Sham-operated animals received no treatment (n = 10). G-CSF injection significantly increased circulating white blood cells, neutrophils, and monocytes. Western blotting revealed that the ratios of MMP-2/TIMP-1 and MMP-9/TIMP-1 were significantly decreased in the infarcted myocardium. At 3 months, echocardiographic and haemodynamic examinations showed that the G-CSF treatment induced left ventricular (LV) enlargement and dysfunction. Histological analysis revealed that the extent of myocardial fibrosis and infarct size were larger in the G-CSF group than in the Saline group. Furthermore, G-CSF treated animals showed a significantly lower post-MI survival during the study period.
CONCLUSION: Decrease of cardiac MMP/TIMP ratios by G-CSF after infarction may be important as a mechanism in promotion of myocardial fibrosis, which further facilitates infarct expansion and LV dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676396     DOI: 10.1093/cvr/cvn202

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  11 in total

1.  Mediators of Prolonged Hematopoietic Progenitor Cell Mobilization After Severe Trauma.

Authors:  Getasha D Doobay; Elizabeth S Miller; Camille G Apple; Tyler J Loftus; Kolenkode B Kannan; Philip A Efron; Alicia M Mohr
Journal:  J Surg Res       Date:  2020-12-26       Impact factor: 2.192

2.  SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion.

Authors:  Xiaolei Liu; Biyan Duan; Zhaokang Cheng; Xiaohua Jia; Lina Mao; Hao Fu; Yongzhe Che; Lailiang Ou; Lin Liu; Deling Kong
Journal:  Protein Cell       Date:  2011-11-06       Impact factor: 14.870

Review 3.  Granulocyte colony-stimulating factor for ischemic heart failure: should we use it?

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

Review 4.  Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond.

Authors:  Santosh K Sanganalmath; Ahmed Abdel-Latif; Roberto Bolli; Yu-Ting Xuan; Buddhadeb Dawn
Journal:  Basic Res Cardiol       Date:  2011-05-04       Impact factor: 17.165

5.  Volume overload induces autophagic degradation of procollagen in cardiac fibroblasts.

Authors:  Lianwu Fu; Chih-Chang Wei; Pamela C Powell; Wayne E Bradley; James F Collawn; Louis J Dell'Italia
Journal:  J Mol Cell Cardiol       Date:  2015-10-24       Impact factor: 5.000

6.  Animal models of cardiac disease and stem cell therapy.

Authors:  Lailiang Ou; Wenzhong Li; Yi Liu; Yue Zhang; Shen Jie; Deling Kong; Gustav Steinhoff; Nan Ma
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

Review 7.  Prooxidant mechanisms in iron overload cardiomyopathy.

Authors:  Ching-Feng Cheng; Wei-Shiung Lian
Journal:  Biomed Res Int       Date:  2013-11-19       Impact factor: 3.411

8.  Combinatorial G-CSF/AMD3100 treatment in cardiac repair after myocardial infarction.

Authors:  Constantin Rüder; Tobias Haase; Annalena Krost; Nicole Langwieser; Jan Peter; Stefanie Kamann; Dietlind Zohlnhöfer
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

9.  The neuroprotective agent Rasagiline mesylate attenuates cardiac remodeling after experimental myocardial infarction.

Authors:  Aimilia Varela; Manolis Mavroidis; Michalis Katsimpoulas; Irini Sfiroera; Niki Kappa; Angelica Mesa; Nikolaos G Kostomitsopoulos; Dennis V Cokkinos
Journal:  ESC Heart Fail       Date:  2017-03-12

10.  Contribution of the polymorphism rs1800469 of transforming growth factor β in the development of myocardial infarction: meta-analysis of 5460 cases and 8413 controls (MOOSE-compliant article).

Authors:  Ling Du; Tao Gong; Minghui Yao; Henghua Dai; Hong Gang Ren; Haitao Wang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.